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An objective measure for the assessment
and management of fluid shifts in acute
major burns
Pippa Kenworthy1,3,6,7* , Michael Phillips5, Tiffany L. Grisbrook1,2, William Gibson6, Fiona M. Wood1,3
and Dale W. Edgar1,3,4

Abstract
Background: Major burns are life threatening. Fluid resuscitation is required for survival to maintain intravascular
volumes and prevent hypovolemic shock. Bioimpedance spectroscopy (BIS) has been recognised as a potential
method of monitoring fluid shifts after burn and in other disease states. The aims of this study were to examine the
reliability of BIS across different dressing conditions and electrode positions, establish the influence of Acticoat™ on
BIS variable measures and determine the validity of whole-body BIS to assess net fluid shift in the presence of
moderate to major burns.
Methods: An observational longitudinal cohort study was conducted from December 2014 to February 2016.
Patients with over 15% total body surface area (TBSA) burns and injury less than 48 h were enrolled in the study.
BIS triplicate measures were collected in an open wound and with an ActicoatTM dressing (at 5 half hour intervals).
Standard and alternate electrode placements were utilised for the reliability analysis and standard placement only
for determining the validity of BIS in moderate to major burns. The ImpediMde SFB7 was used to collect wholebody and segmental BIS measures. Stata statistical software, release 14 was utilised to analyse all results. Descriptive
analyses were performed and were reported using the means and standard deviations (SD).
Results: BIS-repeated measures established BIS raw resistance (R), and predicted volume variables were reliable in
any condition (intra-class correlation coefficient (ICC) 0.996–0.999, 95% confidence intervals (CI) 0.996–0.999) without a
systematic difference. Acticoat™ dressings significantly influenced all BIS-predicted volumes (p ≤ 0.01) as determined by
multilevel mixed effects (MLME) linear regression analysis. Validity of BIS was demonstrated by resistance variables
significantly decreasing with increasing net ionic fluid shift and increased TBSA (severity of injury) and calculated fluid
volumes increasing with increasing net fluid shift and TBSA. BIS resistance also decreased with time as oedema
reduced. For clinical use, a calculator was developed to adjust BIS variables when an Acticoat™ dressing is in situ,
thus facilitating BIS variable change estimates in real time, with dressings intact.
Conclusion: BIS may be used clinically to monitor fluid volume change in major acute burns.
Keywords: Bioelectrical impedance, Oedema, Wounds, Fluid resuscitation, Dressings
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Background
Large fluid shifts and local and distant tissue swelling
are features of burn injuries. Swelling hampers burn
wound healing and the volume created is directly related
to the size and depth of the burn [1]. Major burns
greater than 15–20% total body surface area (TBSA)
with a depth of partial to full thickness result in both a
local and systemic inflammatory response [2, 3]. This
can be a life-threatening scenario which requires formal
fluid resuscitation. Acute burn fluid resuscitation is vital
in decreasing patient morbidity and mortality in the first
24–48 h of injury but can contribute to already large
amounts of oedema [4].
Despite the importance of fluid resuscitation in the early
management of traumatic burn injuries, there is currently
no single, simple, non-invasive and accurate outcome
measure which can assist clinicians to titrate fluid volumes
in acute burns or monitor the effect of treatments on
swelling. Thus, the objective, timely adjustment of fluid
resuscitation is challenging, particularly when patients are
not supported by critical care and invasive monitoring.
This research investigates the accuracy of bioimpedance
spectroscopy (BIS) in monitoring whole-body fluid volume and oedema change in moderate to large acute
burns.
There has been little advancement in the area of burn
fluid resuscitation over the last 30 years [4] and in recent
times, there has been a trend to over resuscitate patients
[5, 6], necessitating a descriptor known as fluid creep. Excess fluid can contribute to burn wound progression, leading to complications such as peripheral and abdominal
compartment syndromes, pulmonary oedema and peripheral tissue oedema. Any one or a combination of these will
affect patient recovery and increase medical costs and is
likely to increase patient length of stay [3, 7–10].
Fluid resuscitation formulas such as the Parkland
and Brookes are used to instigate intravenous (IV)
fluid rates but are guidelines only, and fluid must
then be titrated according to particular endpoints of
resuscitation [11–13]. The most commonly used outcome measure for fluid therapy is urine output, with
the aim to maintain a rate of 30–50 ml per hour for
an average-sized man while preserving haemodynamic
properties such as oxygen saturation and blood pressure [5, 14]. There are other objective measures to
guide volume titration however they are invasive and
not without limitations [6, 14, 15].
BIS has historically been used in healthy populations
to measure body composition. However, in the last
20 years, it has gained increasing popularity in clinical
populations and is now commonly used to measure arm
lymphoedema post breast surgery [16] and dry weight in
haemodialysis patients [17, 18]. BIS has demonstrated
sensitivity, high reliability (repeatability) of measures in a
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number of clinical areas [19]. The method has also been
validated (determined credible) in both healthy and clinical populations against magnetic resonance imaging
(MRI) and bromide and potassium dilution techniques,
which are considered gold standard in the assessment of
fluid compartment volumes and lean body mass (LBM)
[20–23]. It can investigate the body’s physiological parameters such as extracellular fluid (ECF), intracellular
fluid (ICF) and total body fluid (TBF). It achieves this
by passing a small alternating current, over a number
of frequencies (4–1000 kHz), through the tissues and
fluid compartments of the body via electrodes on intact skin. It provides instantaneous measures of resistance (R) and reactance (capacitive resistance (Xc)).
Resistance is the opposition to flow of an electric
current, is reflective of the body’s water compartments and is inversely proportional to fluid volume
and therefore oedema [24, 25]. Capacitance is the
delay in the passage of current through the cell membranes and tissue interfaces [25]. The current flow is
frequency (Hz) dependent and varies according to the
composition of the body [26]. Resistances at zero
(R0) and infinite frequencies (Rinf ) (considered ideal
measurement frequencies) are estimated utilising the
Cole-Cole plot embedded in the BIS software, due to
the constraints of using a direct or very high frequency alternating current in humans [27]. The R0
and Rinf [25] are representative of ECF and TBF respectively. Resistance (Ri) of the ICF is extrapolated
using the other raw variable data. At low frequencies,
the current can penetrate the ECF only, and at high
frequencies, it passes through both the ECF and ICF
measuring TBF.
The ability of BIS to quantify individual body fluid
compartments, the ease of use and non-invasive nature
has led to a small number of papers examining its use in
the burn population. Miller et al. [28] and Zdolsek et al.
[29] were able to determine the development of oedema
post burn injury but each study lacked power and neither was able to provide statistical conclusions regarding
the reliability of BIS in the burns populace. In 2009,
Edgar et al. demonstrated whole-body bioimpedance
spectroscopy was a reliable means of quantifying realtime oedema shifts in patients with burns less than 30%
TBSA across numerous dressing conditions [30]. However, the study only had six participants with burns
greater than 15% TBSA and was therefore inconclusive
in this subset of patients. Further, each study utilised
standard whole-body electrode positions only and it is
unknown whether alternate electrode positions, for both
whole-body and limb segmental BIS, are reliable in this
particular population. Grisbrook et al. (2015) investigated whether alternate electrode configuration BIS
measurements were interchangeable with standard
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electrode configurations in the healthy population but
reliability was not determined [31]. In Edgar et al’s
(2009) study [30], it was also apparent that the dressing
condition affected the sensitivity of the BIS results.
Bioimpedance measures were found to be less sensitive
in older dressings (> 8 h old) than in an open wound or
new dressing condition.
Dressing-type may pose a further challenge in the
assessment of fluid shifts by BIS. Acticoat™ (Smith &
Nephew) is an antimicrobial dressing, composed of
nanocrystalline silver particles [32]. It is the standard
dressing used in the first 48 h of burn care, and as
indicated after, in the Burn Service of Western
Australia (BSWA). Understanding that BIS measures
the resistance of the body’s tissues and intercompartmental fluid volumes by introducing a low
amplitude electrical current into the body, it would
not be unexpected that Acticoat™ may affect the BIS
measures. Silver is a highly conductive material, and
such dressings release ionic silver species and are applied in a wet condition. Both the silver ions and wet
condition would therefore be expected to reduce the
BIS resistance measured, thus potentially limiting the
use of monitoring fluid shifts with BIS in acute burns
patients.
To extend Edgar et al.’s (2009) [30] reliability study
and on the premise that BIS can reliably quantify tissue
fluid, it was hypothesised BIS would provide a method
for real-time accurate measures of fluid shifts in the
acute major burn. The study aimed to examine the reliability with respect to dressing condition and electrode
position, investigate the influence of Acticoat™ on BIS
variable outputs and determine the validity of wholebody BIS to assess net fluid shift in the presence of moderate to major burns, greater than 15% TBSA.

Methods
Participants

An observational longitudinal cohort study was conducted from December 2014 to February 2016. Patients
were recruited into the study if they were over 18 years
old and receiving formal fluid resuscitation and had a
flame and/or scald burn, and the injury was less than
48 h old. The BSWA medical team instigates fluid resuscitation for partial to deep thickness burns greater than
15% TBSA (modified however based on each individuals
clinical presentation and nutritional status at admission)
and uses Ringer’s Lactate (crystalloid) solution with volumes initially determined by the modified Parkland’s
formula. Fluid volumes were titrated to maintain an
adequate urine output of 0.5–1.0 ml/kg/h for the first
36–48 h after burn injury. Participants were excluded
from the research if they had hand and/or feet burns
precluding placement of standard whole-body electrode
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placement and body mass index (BMI) ≤ 15 and ≥ 40 kg/
m2 (manufacturer’s guidelines) and if they met Impedimed
SFB7 (ImpediMed, Brisbane, Queensland, Australia) manufacturer’s contraindications which includes pregnant or
breast-feeding patients, patients with surgical implants,
cardiac pacemakers and/or are on electronic life support
devices (ventilated patients).
Burn inpatients were recruited initially from the Burn
Unit at Royal Perth Hospital (RPH) and then at Fiona
Stanley Hospital (FSH) due to the transition of the
adult care of the BSWA to the new FSH. There was no
change to the study protocol or equipment used in the
study.

Equipment

The ImpediMed SFB7 was used to collect whole-body
and segmental BIS measures (Fig. 1). The calculated
fluid volumes are stable when the subject’s BMI is >
15 kg/m2 (as per the manufacturer).
The BIS equipment measures both raw resistance variables and derived fluid distribution values such as
whole-body ECF, ICF and TBF using the manufacturer’s
algorithms. It achieves this by applying 256 discrete
current frequencies (4–1000 Hz) through the body. ECF
and ICF behave as resistive (R) components and R is inversely proportional to fluid volume [26, 33].
Diagnostic tab electrodes, Kendall CA610 (reference
code 31447793, Covidien, Mansfield, MA, USA), were
utilised.

Procedures

Firstly, the patient’s weight and height was measured and
input into the Impedimed instrument along with their age
and gender. All BIS measures were taken using the manufacturer’s recommended and standardised positions with
the patient lying supine and with the arms and legs
abducted away from the body. BIS electrodes were placed
over intact, cleaned skin (using alcohol swabs).

Fig. 1 Bioimpedance spectroscopy (BIS): standard whole-body
electrode positions
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Electrode configurations

Standardised tetrapolar electrode placements (EP) were
utilised [25, 34], and alternate electrode configurations
were placed based on the theory of equi-potentials (see
Cornish et al. [34] for further details of equipotential
points) and were placed as per Grisbrook et al. [31].
Electrodes were placed on intact skin only. Participants
with bilateral hand or foot injuries which precluded the
application of standardised electrode placements were
excluded. Bioimpedance measures were taken on the
right side of the body unless precluded by wounds, then
the left side was utilised. The location of their wounds
determined whether all other electrode placements (segmental) could be used and measured.
BIS measures were taken in triplicate in an open
wound (time point 0 (T0)) and in the new Acticoat™
dressing condition at five half-hour intervals (T1–T5)
after the baseline measure, i.e. five measures in total
(Fig. 2). The time between T0 and T1 was recorded, as
this was unable to be standardised. Standard and alternate whole-body, upper limb segmental and lower limb
segmental BIS measures were taken at T0–T1. Standard
whole-body EP’s only were utilised at T2–T5 (Fig. 2).
Burn wounds often prevent electrodes being applied in
the standard position; therefore, alternative whole-body
and limb segment electrode positions were utilised as
able at T0–T1 and their reliability investigated. The data
to determine the validity of alternate electrode placement has been analysed separately [35]. The segmental
measures were included in the reliability analysis only.
The effect of Acticoat™ on whole-body BIS results
was determined from T0-T1 BIS readings. Electrodes
remained in situ between triplicate measures where
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possible, unless prohibited by dressing changes or adhesive loss.
Net fluid shift was recorded between each time point
(T1–T5), in conjunction with the BIS measures. Net
fluid shift was calculated by subtracting urine output
and other bodily fluid output recorded (e.g. emesis) from
fluid intake (IV and oral fluids and food).
The researcher was blinded to all BIS measurements
as only a file name was viewed and recorded, not the
actual BIS values.
Data analysis

Stata statistical software, release 14 (StataCorp LP 2014,
College Station, TX), was utilised to analyse all results.
Descriptive analyses were performed and were reported
using the means and standard deviations (SD).
Reliability

A three-level nested mixed effects linear regression was
performed to examine the reliability of the BIS triplicate
measures, taking into account random effects of confounders of electrode position, time and dressing condition. The multilevel mixed effects (MLME) linear
regression also explored whether there was a significant
within-session difference between the triplicate measures
for each of the BIS variables. Reliability is presented as
the intra-class correlation coefficient (ICC) (acceptable,
0.75–0.89, excellent ≥ 0.9) [36], variance indicated by
95% confidence intervals (CI) and systematic bias
between within session trial measures (p < 0.05 considered significant). All BIS triplicate measures were used
in the analysis.

Fig. 2 Consort diagram-flow diagram of data collection process. ICU Intensive care unit, BIS, Bioimpedance spectroscopy
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Analysis was completed using the MLME model as it
can account for random effects from individuals and
responses within individuals [37]. It is a robust method
providing hierarchical analysis, adjusting for nested observations of measures for each individual and giving the most
precise and least biased estimates of treatment effects.
Prior to interpreting the results of the MLME, several
assumptions were evaluated, confirming that each variable
in the regression was approximately normally distributed.
Factors influencing BIS readings

The effect of dressing condition, %TBSA and initial TBF
on the BIS whole-body variables only was determined by
MLME linear regression. A separate model was performed for each BIS variable. The interaction between
Acticoat™ and %TBSA and their influence on the BIS
variables was also examined. The whole-body standard
and alternate electrode placement BIS variable outputs
were grouped together for use in the analysis for the effect
of Acticoat™ and %TBSA. T0 (open wound) and T1 (new
Acticoat™ dressing) were used only.
Validity

Validity was determined using a series of MLME linear regression models including the data with the Acticoat™
dressing condition only, and whole-body standard electrode placement (T1–T5) and alternate electrode placement (T1) only. The final model was produced by
completing step-wise, backward elimination of predictor
variables on each of the dependent BIS variables. The final
model included %TBSA, time, net fluid shift and initial
TBF volume. Initial TBF volume was derived from the
mean of the TBF measured with an open wound using
standard tetrapolar whole-body electrode placement as
single-frequency bioimpedance analysis has been shown
to measure TBF accurately in burns patients with no
dressings [38]. This provided a baseline total body volume
(L). A correlation matrix was performed to determine the
relationship between initial TBF, weight and height and
the skewness-kurtosis test demonstrated that they were
each normally distributed.
Change scores or calculated difference of the BIS variables between time points (e.g. R0 at T1–R0 at T2) were
not used in the validity analysis, as the calculation of a
change score requires measurement of the outcome
twice, and in practice, it is proposed that it is more efficient to use a (single) change from baseline measurement to derive outcomes. In addition by not analysing
change (difference) data, the additive effect of the random errors is potentially reduced [39].
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dressing is in place. Algorithms, for calculation of estimated fluid volumes were developed incorporating the
significant and influential variables (on BIS variables)
from the MLME models.

Results
Twenty-one patients, 7 females and 14 males, were
recruited post burn injury. One patient had an incomplete set of fluid recordings and two patients only had
repeated measures completed four times in the new
Acticoat™ dressing condition. The mean net fluid shift
(SD) at each time point, separated by ~ 30 min for T1–
T5, were as follows: T1 174.72 ml (533.18), T2
189.15 ml (164.23), T3 204.00 ml (135.37), T4 141.48 ml
(253.25) and T5 123.20 ml (114.33). The average time
between T0–T1 (SD) was 67 min (31). The mean TBF
(SD) of patients on initial assessment was 46.06 L (9.71).
Other patient data are presented in Table 1.
Reliability

BIS triplicate measures were reliable within any electrode position, dressing condition and over time.
Table 2 presents that BIS was a reliable measure in
all circumstances, as confirmed by the ICC’s. There
were no significant differences between the estimated
means of within session triplicate trial measures for
each of the BIS variables (i.e. no systematic bias)
(Table 2). Final numbers included in each EP analysis
were whole body standard (WBS) (n = 21), whole body
alternate (WBA) (n = 18), upper limb standard (ULS)
(n = 14), upper limb alternate (ULA) (n = 14), lower
limb standard (LLS) (n = 15), lower limb alternate
(LLA) (n = 14).
The means and CI for each of the BIS variables for the
standard whole-body electrode placement and time
point are presented in Table 3.
Factors influencing BIS readings

The regression analysis demonstrated Acticoat™ had a significant effect on the raw variables Ri and Rinf (but not R0)
and on all the calculated variables (ECF, ICF, TBF) in
whole-body BIS (Table 4). The resistance variables reduced between 182.22 and 23.87 Ω for Ri and Rinf, and the
calculated volumes were increased by 31.00–67.23 L when
an Acticoat™ dressing was in place, compared to the open
wound condition.
Table 1 Patient data (n = 21)
%TBSA

Age
(years)

Recruitment post
burn injury (h)

Height
(cm)

Weight
(kg)

Calculator

24 (13) range
12–80

36.4
(13.5)

25 (11)

172.2

77.4
(16.3)

A calculator was developed to estimate the net fluid shift
between consecutive BIS measures, when an Acticoat™

Values presented as means (SD) ± range
TBSA total body surface area
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Table 2 BIS reliability
BIS
variable

ICC (95% CI)

BIS trial
number*

BIS measure
coefficient
(95% CI)

p value

R0

0.999 (0.999–0.999)

2

− 0.07 (− 0.68–0.54)

0.83

3

− 0.06 (− 0.68–0.55)

0.84

Ri

0.999 (0.998–0.999)

2

0.41 (− 1.90–2.71)

0.73

3

2.06 (− 0.24–4.37)

0.80

Rinf

0.9996(0.999–0.999)

2

0.01 (− 0.30–0.32)

0.94

3

0.07 (− 0.24–0.38)

0.66

ECF

0.999 (0.998–0.999)

2

0.03 (− 0.17–0.22)

0.78

3

0.12 (− 0.07–0.32)

0.22

ICF

0.997 (0.996–0.998)

2

− 0.12 (− 0.46–0.22)

0.49

3

− 0.26 (− 0.61–0.08)

0.13

TBF

0.999 (0.999–0.999)

2

− 0.09 (− 0.38–0.20)

0.53

3

− 0.14 (− 0.43–0.15)

0.33

ICC intraclass correlation coefficient, R0 resistance at zero frequency, Ri
intracellular resistance, Rinf resistance at infinite frequency, ECF extracellular
fluid, ICF intracellular fluid, TBF total body fluid, BIS bioimpedance
spectroscopy, CI confidence intervals
*Each BIS measure coefficient is in reference to measure 1 of the
triplicate measures

There was no evidence of an effect of TBSA on any of the
BIS variables (Table 4). However, there was a statistically significant interaction (p < 0.01) between %TBSA and Acticoat™
for all BIS variables, raw and calculated. When an Acticoat™
dressing was in place and for every 1% increase in %TBSA
R0 decreased by 4.68 Ω, Ri by 17.98 Ω and Rinf by 3.96 Ω.
This results in a divergence away from the open wound R
values as %TBSA increases. ECF, ICF and TBF volumes all
increased with greater %TBSA when an Acticoat™ dressing
was in place also resulting in divergence away from the open
wound fluid volumes as %TBSA increased (Table 4).

As expected, there was a strong positive correlation
between initial TBF and weight, with a correlation
coefficient (r) of 0.83 (p < 0.01). There was also a
moderate positive correlation between initial TBF and
height, r = 0.67 (p < 0.01). Initial TBF was therefore
included in the model, and height omitted, to reduce
collinearity. Initial TBF was included in preference to
BMI as it was determined to be a more robust indicator of a person’s size as the random error was reduced when compared to BMI (as it is one variable
compared to two (height and weight)). Initial TBF is
significantly associated with all BIS variables. For
every 1 L increase in initial TBF, R0 decreased by
5.71 Ω (p < 0.01), Ri decreased by 32.52 Ω (p < 0.01)
and Rinf decreased by 5.30 Ω (p < 0.01). All estimated
fluid volumes increased (ECF 0.93 L, ICF 1.08 L, TBF
2.02 L) with every 1 L increase in initial TBF.
Algorithms were developed to correct for the effect of
Acticoat™ for the BIS variables. They are as follows:
Corrected ECF = measured ECF with Acticoat dressing – (− 59.02 + (time since dressing applied × 1.38)
+ (initial measured ECF × 2.69))
Corrected ICF = measured ICF with Acticoat dressing – (− 79.26 + (time since dressing applied × − 0.0006)
+ (%TBSA × 1.85) + (initial measured ICF × 3.088918)).
Validity

BIS resistance and fluid volume variables were analysed
to determine BIS validity. The MLME linear regression
univariate analysis, in the Acticoat™ dressing condition
only, showed R0, Ri and Rinf significantly changed with
time (Table 5). Compared to T1 (new Acticoat™ dressing), for every minute increase in time, R0 decreased by
0.40 Ω (p < 0.01), Ri decreased 2.51 Ω (p < 0.01) and Rinf

Table 3 BIS variable values for the standard whole-body electrode placement and time point
BIS
variable
at WBS

Time point
T0

T1

T2

T3

T4

T5

R0 (ohms)

498.77
(467.17–530.37)

351.94
(295.56–408.32)

366.70
(314.94–418.45)

371.18
(319.50–422.86)

371.76
(322.20–422.33)

401.01
(348.18–453.84)

Ri (ohms)

1412.47
(1225.51–1599.42)

715.75
(505.83–925.68)

715.51
(536.09894.93)

721.81
(546.31–897.31)

713.41
(541.38–885.44)

798.52
(611.02–986.02)

Rinf
(ohms)

361.89
(337.57–386.20)

226.58
(183.50–269.67)

234.35
(195.19–273.52)

237.45
(198.23–276.67)

238.65
(200.24–277.06)

261.95
(220.50–303.40)

ECF (L)

20.76
(17.56–23.97)

34.77
(14.00–55.54)

32.50
(13.22–51.78)

31.93
(14.21–49.66)

31.50
(15.07–47.92)

24.84
(10.44–39.25)

ICF (L)

25.26
(21.62–28.91)

48.47
(27.74–69.21)

46.97
(27.11–66.83)

46.71
(27.15–66.27)

46.18
(27.20–65.16)

37.80
(21.38–54.23)

TBF (L)

46.03
(39.67–52.38)

83.16
(43.11–123.20)

79.48
(41.84–117.12)

78.53
(42.85–114.20)

77.65
(43.18–112.11)

62.65
(33.67–91.63)

Values presented as means (confidence intervals)
BIS bioimpedance spectroscopy, WBS standard whole-body electrode position, R0 resistance at zero frequency, Ri intracellular resistance, Rinf resistance at infinite
frequency, ECF extracellular fluid, ICF intracellular fluid, TBF total body fluid, T0 initial BIS measurement with no dressing, T1 first BIS measure with new Acticoat™
dressing, T2–T5 BIS measures taken at half hourly intervals
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Table 4 Predictor variable effects on whole-body BIS variables
for determining the effect of Acticoat™
BIS
variable
R0 (ohms)

Ri (ohms)

CoConfidence intervals p value
efficient
Lower
Upper

BIS
variable

Acticoat™

− 17.42

− 39.35

4.52

0.12

R0 (ohms)

% TBSA

− 1.07

− 2.75

0.61

0.21

Acticoat™#% TBSA − 4.68

− 5.37

− 3.98

< 0.01*

Net fluid shift (ml) − 0.05

− 0.07

− 0.02

< 0.01*

Initial TBF (L)

− 5.71

− 8.32

− 3.09

< 0.01*

Initial TBF (L)

− 5.78

− 8.95

− 2.61

< 0.01*

Acticoat™

− 182.22 − 265.27

% TBSA

6.50

Covariate

Time (minutes)

− 0.40

− 0.54

− 0.27

< 0.01*

% TBSA

− 5.09

− 7.08

− 3.10

< 0.01*

− 99.16

< 0.01*
0.20

Acticoat™#% TBSA − 17.98

− 20.61

− 15.36

< 0.01*

Net fluid shift (ml) − 0.25

− 32.52

− 48.16

− 16.87

< 0.01*

Initial TBF (L)

% TBSA

− 23.87

− 38.57

− 9.17

< 0.01*

− 0.01

− 1.33

1.32

0.99

Time (minutes)

− 2.51

− 3.09

− 1.92

< 0.01*

% TBSA

− 8.85

− 16.98

− 0.74

0.03*

Rinf (ohms) Time (minutes)
% TBSA

− 28.79

− 0.36

− 0.15

< 0.01*

− 41.74

− 15.84

< 0.01*

− 0.40

− 0.51

− 0.28

< 0.01*

− 3.25

− 4.69

− 1.81

< 0.01*

Acticoat™#% TBSA − 3.96

− 4.42

− 3.49

< 0.01*

Net fluid shift (ml) − 0.05

− 0.07

− 0.03

< 0.01*

− 5.30

− 7.37

− 3.23

< 0.01*

Initial TBF (L)

− 5.38

− 7.68

− 3.07

< 0.01*

Acticoat™

− 36.23

− 41.91

− 30.55

< 0.01*

Time (minutes)

0.02

− 0.01

0.05

0.15

% TBSA

− 0.04

− 0.31

0.23

0.76

% TBSA

1.40

0.99

1.80

< 0.01*

Acticoat™#% TBSA 1.86

1.68

2.04

< 0.01*

Net fluid shift (ml) 0.01

− 0.001

0.01

0.09

Initial TBF (L)

0.93

0.53

1.33

< 0.01*

Initial TBF (L)

0.56

1.85

< 0.01*

Acticoat™

− 31.00

− 36.07

− 25.92

< 0.01*

Time (minutes)

0.06

0.03

0.10

< 0.01*

% TBSA

− 0.15

− 0.36

0.07

0.18

% TBSA

1.52

1.17

1.88

< 0.01*

Acticoat™#% TBSA 2.01

1.85

2.17

< 0.01*

Net fluid shift (ml) 0.01

0.01

0.02

< 0.01*

Initial TBF (L)

1.08

0.77

1.40

< 0.01*

Initial TBF (L)

0.99

2.13

< 0.01*

Acticoat™

− 67.23

− 77.13

− 57.32

< 0.01*

Time (minutes)

0.08

0.02

0.14

< 0.01*

% TBSA

− 0.19

− 0.63

0.25

0.40

% TBSA

2.92

2.18

3.65

< 0.01*

Acticoat™#% TBSA 3.87

3.55

4.18

< 0.01*

Net fluid shift (ml) 0.02

0.01

0.03

< 0.01*

Initial TBF (L)

1.36

2.67

< 0.01*

Initial TBF (L)

1.59

3.94

< 0.01*

Initial TBF (L)

TBF (L)

CoConfidence intervals p value
efficient
Lower
Upper

16.46

Rinf (ohms) Acticoat™

ICF (L)

Ri (ohms)

Covariate

− 3.45

Initial TBF (L)

ECF (L)

Table 5 Univariate analysis of variable correlation on wholebody BIS measures

2.02

Acticoat™ is in reference to an open wound
R0 resistance at zero frequency, Ri intracellular resistance, Rinf resistance at
infinite frequency, ECF extracellular fluid, ICF intracellular fluid, TBF total body
fluid, TBSA total body surface area, BIS bioimpedance spectroscopy
*p ≤ 0.05
#Interaction term

decreased 0.40 Ω (p < 0.01). The BIS-calculated fluid volumes ICF and TBF were also significantly associated
with time, increasing by 60 and 20 ml for every minute
increase in time (p < 0.01). ECF was not significantly associated with time.
The regression analyses demonstrated all resistance
values significantly decreased with increasing net fluid
volume in a linear relationship (Table 5, Fig. 3a). Net
fluid volume was significantly associated with ICF and
TBF BIS fluid volume change, increasing with increasing
net fluid shift (Fig. 3b). All BIS variables were significantly associated with % TBSA. For every 1% increase in
TBSA, R0 decreased by 5.09 Ω, Ri decreased 8.85 Ω and
Rinf decreased 3.25 Ω. Fluid volumes increased between
1.20–2.77 L with every 1% increase in TBSA (p < 0.01)
(Table 5).

ECF (L)

ICF (L)

TBF (L)

1.20

1.56

2.77

R0 resistance at zero frequency, Ri intracellular resistance, Rinf resistance at
infinite frequency, ECF extracellular fluid, ICF intracellular fluid, TBF total body
fluid, TBSA total body surface area, BIS bioimpedance spectroscopy
*p ≤ 0.05

Two individuals who had large negative fluid shifts
> 850 ml across a single time point were removed
from the analysis after the stepwise analysis found
that they significantly altered the results of the final
model. Leaving these patients in the analysis would
have resulted in a non-homogenous sample. It
appears a large loss of fluid volume compromises the
interpretation of BIS measures. Both patients suffered
loss of large volumes of ionic fluid due to emesis
which likely altered the measured BIS resistance [27].
When a patient’s initial TBF increased by 1 L, R0
decreased by 5.78 Ω (p < 0.01), Ri decreased 28.79 Ω
(p < 0.01) and Rinf decreased 5.31 Ω (p < 0.01).
Calculator

A calculator was developed to estimate the net fluid shift
between consecutive BIS measures, accounting for
dressing condition, %TBSA and time since dressing
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to large burn patients. Bioimpedance resistance measures can be interpreted in the presence of Acticoat™ to
monitor changes in fluid volume over time, if corrected
for using the provided calculator. Thus, the study also
established BIS as a valid indicator of fluid change over
time during burns resuscitation while Acticoat™ dressings are in situ. BIS at the bedside has the potential to
improve fluid management in an acute major burn by
providing real-time measures of fluid shifts thus reducing the risk of over resuscitation and associated adverse
outcomes.
Reliability

b

The results of the study demonstrate BIS produces reliable raw and predicted measures in patients with > 12%
TBSA burns, regardless of dressing condition (open
wound or Acticoat™) and electrode placement (Table 5).
This data suggests BIS is a reliable method for assessing
oedema change over time in moderate to large area
burns. This concurs with and adds to the findings of
Edgar et al.’s (2009) study which found BIS reliability
applicable to burns with < 30% TBSA across different
dressing conditions [30].
Factors influencing BIS readings

Fig. 3 a, b Predicted margin plots of BIS variable (Ri, ICF) and net
fluid shift relationship. *The predicted margin plots of R0 and Rinf
have a similar linear relationship to net fluid shift as Ri. ECF and TBF
have a similar linear relationship to net fluid shift as ICF. R0, Resistance
at zero frequency; Ri, Intercellular resistance; Rinf, Resistance at infinite
frequency; ECF, Extracelluar fluid; ICF, intracellular fluid; TBF, total body
fluid

(Additional file 1). The significant and influential
variables from the MLME models (Table 5) were incorporated into the newly developed algorithms (for calculation of fluid volumes), which were then embedded in
an excel calculator to allow clinicians access to them.
The variables required for input into the calculator by
the clinician include dressing condition, %TBSA, time
since application of Acticoat™ dressing (minutes) and the
measured BIS variables. The calculator does not require
the clinician to monitor or include net fluid shift, namely
urine output and fluid input.
The validity analysis utilised the measured BIS fluid
volumes and did not correct for the Acticoat™ effect, as
it was not considered necessary for this preliminary
study.

Discussion
The principal novel finding of this study show BIS was a
reliable method for monitoring fluid change in moderate

Whole-body bioimpedance-calculated fluid volumes
were grossly and significantly overestimated, and resistance of the ICF and TBF was underestimated when an
Acticoat™ dressing was in place. The under or overestimation of BIS variables increased with increasing TBSA.
Grisbrook et al. [40] and Kenworthy et al. [35] also
found that the effect of silver dressings on BIS variable
measures increased with increasing size of the burn.
BMI is also well known to be associated with BIS variable output as larger people have a greater amount of
body fluid [41]. This has been demonstrated in the
present results where a larger initial TBF (indication of
the bulk of the person and collinear with BMI) significantly decreased BIS resistance and therefore increased
calculated fluid volumes.
It can be concluded that BIS was appropriate for use
in a moderate to large burns population when an Acticoat™ dressing was in place only with adjustment, as
resistance measures and fluid volumes are significantly
under and overestimated with significantly different values
to those in an open wound. The SFB7 impedimedembedded algorithms are not appropriate for use in burns
with Acticoat™ in situ. This is consistent with the findings
of Grisbrook et al. [40] though the burns population sample in that study did differ from those recruited in this
study sample with respect to %TBSA (range 5.5–28.5%
compared to our 12–80%) and fluid resuscitation requirements. Therefore, to monitor fluid shifts, it is recommended that the resistance and fluid volume variables
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measured when an Acticoat™ dressing, in situ, be corrected using the provided calculator.
Validity

The present results show that BIS is a valid indicator of
fluid volume change over time in moderate to large burn
resuscitation with TBSA, time, net fluid shift and initial
TBF all significantly associated with BIS resistance and
calculated fluid volumes. For clinically interpretable
results, the measured BIS variables need to be adjusted
using the provided calculator if Acticoat™ is in place.
Time was significantly associated with resistance variables, with an increase in time decreasing all estimated
resistances and increasing ICF and TBF volumes. This
may be explained by a combination of factors including
the time since dressing application, the effect of Acticoat™ and the amount of fluid resuscitation administered. Firstly, over time the Acticoat™ dressing deposits
more silver ions into the wound, therefore decreasing
the raw resistance values and in turn increasing the
‘equivalent’ fluid volumes as calculated by BISembedded algorithms [42]. Secondly, the total mean volume of fluid resuscitation over time increased, thus increasing all inter-compartmental fluid volumes and
consequentially decreasing the associated estimated resistance values. Although ECF was not associated with
time, the p value (0.15) is arguably low enough to accept
that a clinical relationship may exist despite a small sample. In contrast, the embedded algorithm of analysis may
explain why ECF is not associated with time in this
population (each algorithm has different constants for
estimating the individual fluid compartments [43]).
However, R0, the equivalent resistance of ECF significantly changed with time, suggesting fluid volume
change in the extracellular compartment is associated
with time.
It is known that BIS resistance is inversely proportional to fluid volume [22, 24]. The results of this study
support this. Bioimpedance variables and net fluid shift
were found to have a negative inverse linear relationship
with resistance and as expected, calculated fluid volumes
a positive linear relationship (Fig. 3) provided that the
net fluid shift (at each half hour measure) was greater
than 100 ml. There were two patients who had a large
(> 850 ml) negative fluid shift, both noted to have emesis
during the single measurement period, and thus, these
data were excluded from the analysis, as they were
assumed to have an altered, uncorrected physiological
(ionic) state at the time of measurement and thus, significantly differed from others in the sample. It appears
that a large loss of fluid consequentially affects the following repeated BIS measures (within at least the following 2 h). It is proposed that not only was the volume
change a contributor to the difficulty in interpretation of
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the BIS measures but also the loss of electrolytes from
the gut following emesis. The emesis could have altered
the whole-body fluid ionic state for a short period until
it was corrected by the body systems. Bioimpedance resistance is inversely proportional to fluid volume and
electrolyte concentration. Therefore, significant changes
in the ionic status of the fluid or tissues measured will
alter the BIS raw variables and render the machineembedded algorithms for calculated volumes invalid. Clinicians are advised not to use BIS measures in the
period after an episode of emesis [27]. Further, the results suggest the BIS measure is only sensitive to fluid
losses ≤ 100 ml per half hour in the burns resuscitation
period. The sensitivity of the BIS measure for fluid losses
greater than 100 ml and less than 850 ml cannot be predicted as the patient cohort did not experience losses in
this range.
Calculator

On the basis of the results a calculator was developed to
improve the clinical utility of BIS in burns resuscitation
patients at the bedside. It adjusts for the Acticoat™ effect
and provides an estimated change in BIS resistance and
fluid volumes between consecutive BIS measurements,
hence allowing fluids to be titrated accordingly. It has
been established however that BIS is reliable and valid in
the open wound condition. Therefore, BIS can be utilised without variable adjustment when no dressings are
in place.
Clinical practice recommendations

Optimum fluid resuscitation requires maintenance of the
intracellular volume with minimal expansion (extravasation) of the extracellular volume. The results of this study
indicate that using the relationship or pattern between R0
or ECF and Ri or ICF is a non-invasive, interpretable
method of monitoring or titrating fluid resuscitation. A
stabilised Ri or ICF volume, over time, equal to or greater
than the normal range (ICF 22.9–25 L) [24] represents a
fluid resuscitation target. Fluid volumes should then be
titrated to maintain R0 or ECF at a steady state whilst continuing to preserve Ri or ICF at the target volume. Ideally
ECF volumes would be maintained as close to normal (or
the average for a healthy person) as possible (13.2–15.3 L).
However due to the body’s systemic “leaky vessel” inflammatory response to a major burn injury, with extravasation of fluid into the extracellular space, volumes within
5–10% of these norms would be a suggested acceptable
target range [44, 45]. In postoperative surgical patients,
fluid overload has been defined as > 15% of preoperative
fluid volume [44] and in haemodialysis patients reaching
ECF volumes within one to two litres of normal values is
deemed acceptable [46]. An example of how to titrate
fluids: If Ri or ICF is stable and the change values of R0 or
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ECF continue to increase, the fluid administered is adding
to the extracellular compartment (swelling) rather than
preferentially maintaining the intracellular compartment.
Infused fluid volumes therefore need to be reduced if Ri
(ICF) is stable and R0 (ECF) is trending upward. However,
in a recent study, intracellular volume actually decreased
(~ 0.8 L over 70 min) upon rapid infusion of intravenous
fluid (~ 2 L in ~ 60 min) into healthy male volunteers [47].
It was suggested that the infusion of fluid was responsible
for the increase in ECF. The fluid administered in this
study was < 500 ml/h; therefore, it is difficult to conclude
whether this may have the same effect. It however does
suggest potentially accepting an ICF volume of ~ 1 L less
than the average volumes when considering titrating fluid
as above. For greater sensitivity to change, at this time,
this study suggests that it is more advantageous to use the
change in BIS raw resistance values (adjusted in the presence of Acticoat™) rather than the calculated volumes as it
removes the need for specific predictive equations and
eliminates the need for height and weight measures [48].
There are a growing number of studies suggesting that
raw BIS variables may be more useful in predicting clinical
outcomes [49, 50]. BIS raw variables may also be able to
indicate changes associated with cell membrane damage
and cell wall integrity [50].
Further work is required to increase the confidence
and promote greater utility of this sensitive measure
over standard haemodynamic monitoring. In contrast,
urine output, a ‘quasi’ measure of fluid shifts and wholebody perfusion [8] has been suggested to lag behind the
actual events of hypoperfusion by up to 2 h [51, 52].
Bioimpedance also removes the need to rely heavily on
initial fluid volume calculations such as the Parkland or
Brooke’s. This proves to be highly useful out in the field
with paramedics and in isolated country hospitals where
clinician’s burns experience may be limited and where
Western Australia’s vastness means it is not uncommon
for people to travel greater than 8 h to be admitted to a
tertiary hospital.

Future research

Additional research is warranted in evaluating the effect
of other silver and non-silver dressings such as sulfadiazine and hydrocolloids, in moderate to large burns to increase the utility of BIS across burns services.
Further, consideration may need to be given of the
type of resuscitation fluid (e.g. crystalloids versus colloids) in future studies as BIS electrical conductivity is
affected by electrolyte concentration. This may therefore
influence BIS variable measurements. Electrical and
chemical burn injuries may also influence or change the
ionic state of the tissue. Thus, future research should include these modes of injury.
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Ideally, BIS would be able to be used on burns patients
on life support or mechanical ventilation however further study needs to be done to determine whether electronic equipment interferes with the BIS instrument.
Several studies have been conducted in intensive care
units however they did not stipulate whether ventilated
patients were included [53, 54].

Conclusions
In moderate to large burn patients, BIS is a reliable and
valid method of oedema change. The Acticoat™ dressings
significantly alter the BIS raw outputs. To allow clinical
interpretation of BIS, measures must be adjusted for silver
dressings.
Additional files
Additional file 1: Acticoat calculator for oedema—excel spreadsheet.
(XLSX 13 kb)
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